Filing Details

Accession Number:
0001567619-18-001687
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-23 08:51:52
Reporting Period:
2018-08-03
Accepted Time:
2018-08-23 08:51:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380177 Ronald Richard 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-03 100 $14.71 21,063 No 4 M Direct
Common Stock Disposition 2018-08-03 100 $60.00 20,963 No 4 S Direct
Common Stock Acquisiton 2018-08-21 7,793 $14.71 28,756 No 4 M Direct
Common Stock Disposition 2018-08-21 7,793 $60.02 20,963 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-08-03 100 $14.71 100 $14.71
Common Stock Stock Option (Right to Bury) Disposition 2018-08-21 7,793 $14.71 7,793 $14.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,793 2020-05-19 No 4 M Direct
0 2020-05-19 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to 60.05, inclusive.
  3. Consists of an option granted under the company's stock incentive plan as amended and restated.
  4. The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.